Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based drug design: progress, results and challenges

C L Verlinde1, W G Hol

  • 1Department of Biological Structure, School of Medicine, University of Washington, Seattle 98195.

Structure (London, England : 1993)
|July 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probing the limits of the molecular replacement method: the case of Trypanosoma brucei phosphoglycerate kinase.

Acta crystallographica. Section D, Biological crystallography·2004
Same author

Structure of cephalosporin acylase in complex with glutaryl-7-aminocephalosporanic acid and glutarate: insight into the basis of its substrate specificity.

Chemistry & biology·2002
Same author

Glycolysis as a target for the design of new anti-trypanosome drugs.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2001
Same author

A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.

Journal of medicinal chemistry·2001
Same author

Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.

Journal of molecular biology·2001
Same journal

Structure of Perinereis linea erythrocruorin reveals a compact extracellular globin megacomplex.

Structure (London, England : 1993)·2026
Same journal

Meet the author: Stephen Brohawn.

Structure (London, England : 1993)·2026
Same journal

Tetraspanins bring Norrin into focus: Structural insights into ligand-specific Wnt signaling.

Structure (London, England : 1993)·2026
Same journal

Uncovering subtype-selective activation of the K<sub>Ca</sub>3.1 channel by SKA-111.

Structure (London, England : 1993)·2026
Same journal

Identification and structure determination of a type III-Bv CRISPR complex that post-translationally modifies an associated toxin.

Structure (London, England : 1993)·2026
Same journal

Cryo-EM structure of the Arabidopsisthaliana ribosome in translating and non-translating states.

Structure (London, England : 1993)·2026
See all related articles

Protein structure-based drug design is rapidly advancing. This field offers incredible new opportunities and results, far exceeding expectations from just ten years ago.

Area of Science:

  • Drug discovery and development
  • Structural biology
  • Computational chemistry

Background:

  • Protein structure-based drug design is a rapidly evolving field.
  • Recent advancements have significantly accelerated progress.

Purpose of the Study:

  • To highlight the rapid momentum and transformative potential of protein structure-based drug design.
  • To underscore the remarkable progress and opportunities in the field.

Main Methods:

  • Structure determination of target proteins
  • Computational modeling and simulation
  • Ligand docking and virtual screening

Main Results:

  • Unprecedented opportunities in drug design.

Related Experiment Videos

  • Significant improvements in success rates for identifying drug candidates.
  • Accelerated timelines for drug development.

    • Conclusions:

    • Protein structure-based drug design is revolutionizing pharmaceutical research.
    • The field's rapid progress offers immense potential for future therapeutic breakthroughs.